A drug commonly used to treat cancer can restore memory and cognitive function in mice that display symptoms of Alzheimer's disease, new research has found. The drug, Axitinib, inhibits growth of new blood vessels in the brain -- a feature shared by both cancer tumors and Alzheimer's disease. This hallmark represents a new target for Alzheimer's therapies. Mice that underwent the therapy not only exhibited a reduction in blood vessels and other Alzheimer's markers in their brains, they also performed remarkably well in tests designed to measure learning and memory.
source https://www.sciencedaily.com/releases/2021/10/211005124658.htm
Wednesday, 6 October 2021
Related Posts
Mimicking SARS-CoV-2 nasal infection in monkeysA new rhesus macaque animal model recapitulates the clinical and patho… Read More
Common SARS-CoV-2 mutation may make COVID-19 more susceptible to a vaccineA common strain of coronavirus has mutated to help it spread quickly, … Read More
Study finds lasting fatigue common after COVID-19 infectionMore than half of people with acute COVID-19 infection continue to hav… Read More
Smell and taste changes provide early indication of COVID-19 community spreadSelf-reports of smell and taste changes provide earlier markers of the… Read More
How organ functions were shaped over the course of evolutionA large-scale study conducted by molecular biologists has yielded grou… Read More
Cloth face masks that can be disinfected by the sunResearchers have developed a special type of cotton face mask that kil… Read More
0 comments: